Header image

Das Viswanath M.Sc., Ph.D.
Impact factor journals
Nucleoside-based anticancer drugs: mechanism of action and drug resistance.
Biochemical Pharmacology.
2023,
ISSN: 0006-2952 ,
PMID: 37567317,
New use of Old Drugs: Repurposing of Non-oncology Drugs for Cancer and Oncology Drugs for other Human Diseases.
Anti-cancer Agents in Medicinal Chemistry.
2023,
23(10),
1103,
ISSN: 1871-5206,
PMID: 37271990,
Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
Brain.
2023,
ISSN: 0006-8950,
PMID: 37243427,
Books
Laboratory Techniques in Cellular and Molecular Medicine,
1.vyd.,
Olomouc,
Palacky University,
2021,
436 s,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Book chapters
Cell lines and cell culture conditions - 3D cultures ,
1.vyd.,
Olomouc,
Palacky University,
2021,
2,
15,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Multiparametric analysis of spheroid integrity by brightfield high-content microscopy ,
1.vyd.,
Olomouc,
Palacky University,
2021,
24,
177-182,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
A combination of kinetic fluorometric assay and microscopy for the screening of potential anti-tau aggregating agents,
1.vyd.,
Olomouc,
Palacky University,
2021,
41,
317-324,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Doctoral mentorship
Annadurai Narendran M.Sc., Ph.D.
Identification and Characterisation of Tau Minimal Regions as Potential Pharmacological Targets Against Tau Spreading in Tauopathies
Status:
Graduated from 2015 to 2023.
Master mentorship
Bechná Eliška
3D spheroids cultures of tumor cell lines for drug discovery studies
Status:
Ongoing from 2022.
Pavlíková Martina
Specific pharmacological modulators of tau aggregation and spreading for Alzheimer's disease preclinical studies.
Status:
Ongoing from 2022.
Skoupilová Patricie
Examination of mutations in tau on the activity of small molecules against prion-like tau formation in tauopathies
Status:
Ongoing from 2023.
Bachelor mentorship
Chudáčková Alice
Biochemical and Cellular Analysis of Amyloid Staining Agents in Models of Tauopathies and Synucleopathies
Status:
Ongoing from 2023.
Vrablíková Barbora
Cytotoxicity of microtubule-stabilizing drug laulimalide in hypoxic human colorectal and cervical cancer cells
Status:
Graduated from 2018 to 2020.
Open positions
Project: | The role of tumor hypoxia in the development of acquired resistance to microtubule-targeted drugs |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | 1 place in full-time study |
Project: | A combination of 2D and 3D cell cultures for a smart and effective identification and characterization of anti-hypoxic candidates |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | Hypoxia is a prominent feature of different solid tumor types. A central component of hypoxic adaptation is the stabilization of hypoxia-inducible factor-1 (HIF-1), a key transcriptional regulator of hypoxia that orchestrates the transcriptional regulation of genes involved in a plethora of cellular processes. Considering the multiple roles of HIF-1 in cancer, interest in novel small-molecule inhibitors of the HIF-1 pathway has steadily increased over the past 10 years. However, despite extensive research, no specific inhibitor of HIF-1 has been brought to the market, making the field still ripe for further exploration. The goal of the present work is to utilize the potential of a combination of 2D and 3D cellular models for identification and characterization of inhibitors of HIF-1 and/or HIF-1 pathway by screening in 2D cultures, and lightsheet microscopy and mass spectrometry studies in spheroid cultures. |
Project: | An extensive structural and biochemical characterization of tau oligomeric species in Alzheimer’s disease and other tauopathies |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | An extensive structural and biochemical characterization of tau oligomeric species in Alzheimer’s disease and other tauopathies |
Project: | The role of tumor hypoxia in the acquisition of resistance to microtubule-targeting drugs |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | Hypoxia is one of the major factors causing resistance to microtubule-stabilizing drugs (MSDs) and other non-microtubule drugs used in chemotherapy. Hypoxia results in changes in tubulin conformation, expression of tubulin isotypes and metabolic pathways that make cancer cells less susceptible to paclitaxel, a taxane used extensively in the treatment of solid tumors. Recent cellular studies have shown that non-taxane MSDs with a similar mode of microtubule stabilization to paclitaxel is more effective in hypoxic cancer cells than paclitaxel. Due to a different microtubule-binding site, we hypothesize that non-taxane MSDs may have a better cytotoxic effect in cancer cells under hypoxia. The goal of this project is to study the anti-cancer effect of non-taxane MSDs in hypoxic ovarian and cervical cancer cell models. |
Project: | Systems approaches to understanding aging and neurodegeneration |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Project: | The role of tumor hypoxia in the development of acquired resistance to microtubule-targeted drugs |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Project: | Research and development of agents for cancer, neurodegenerative and infectious diseases |
---|---|
Supervisors: | De Sanctis Juan Bautista Ph.D., Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D., Urban Milan Ph.D., Das Viswanath M.Sc., Ph.D. |
Available: | 5 |
Intended for: | Doctoral training |
Project: | Role of axonal transport and pathology in neurodegeneration |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Project: | Development of organoid assays for anti-tumour drug screening |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 2 |
Intended for: | Bachelor training |
Project: | Biochemical and cellular analysis of amyloid staining agents in models of tauopathies and synucleopathies |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 2 |
Intended for: | Bachelor training |
Project: | Drug synergy studies in 3D spheroids cultures of tumour cell lines |
---|---|
Supervisors: | Das Viswanath M.Sc., Ph.D. |
Available: | 2 |
Intended for: | Bachelor training |